Healthcare provider profile · identity verified

Roberta Joseph

Internal Medicine · DELRAY BEACH, FL · NPI 1275094773

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	232
Albuterol Sulfate Hfa	Albuterol Sulfate	182	119
Amlodipine Besylate	Amlodipine Besylate	180	138
Diclofenac Sodium	Diclofenac Sodium	179	148
Losartan Potassium	Losartan Potassium	157	108
Metformin Hcl	Metformin Hcl	145	103
Lisinopril	Lisinopril	136	103
Rosuvastatin Calcium	Rosuvastatin Calcium	130	87
Gabapentin	Gabapentin	125	91
Methylprednisolone	Methylprednisolone	118	110
Azithromycin	Azithromycin	106	89
Fluticasone Propionate	Fluticasone Propionate	99	82
Levothyroxine Sodium	Levothyroxine Sodium	99	68
Pantoprazole Sodium	Pantoprazole Sodium	99	80
Alendronate Sodium	Alendronate Sodium	82	42
Hydrochlorothiazide	Hydrochlorothiazide	81	58
Famotidine	Famotidine	74	63
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	55
Metoprolol Succinate	Metoprolol Succinate	72	53
Glipizide	Glipizide	71	52
Tizanidine Hcl	Tizanidine Hcl	70	55
Tamsulosin Hcl	Tamsulosin Hcl	67	58
Carvedilol	Carvedilol	65	47
Alprazolam	Alprazolam	56	24
Triamcinolone Acetonide	Triamcinolone Acetonide	56	44
Nifedipine Er	Nifedipine	54	41
Ibuprofen	Ibuprofen	52	42
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	29
Trazodone Hcl	Trazodone Hcl	47	32
Metformin Hcl Er	Metformin Hcl	46	27
Omeprazole	Omeprazole	46	36
Furosemide	Furosemide	42	34
Metoprolol Tartrate	Metoprolol Tartrate	42	32
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	34
Montelukast Sodium	Montelukast Sodium	38	26
Prednisone	Prednisone	31	21
Ozempic	Semaglutide	30	11
Sertraline Hcl	Sertraline Hcl	29	24
Mirtazapine	Mirtazapine	28	21
Clopidogrel	Clopidogrel Bisulfate	27	16
Eliquis	Apixaban	27	18
Ondansetron Odt	Ondansetron	27	26
Sildenafil Citrate	Sildenafil Citrate	27	12
Potassium Chloride	Potassium Chloride	26	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Simvastatin	Simvastatin	25	23
Escitalopram Oxalate	Escitalopram Oxalate	24	11
Pravastatin Sodium	Pravastatin Sodium	24	14
Warfarin Sodium	Warfarin Sodium	24	12
Duloxetine Hcl	Duloxetine Hcl	22	15
Latanoprost	Latanoprost	22	suppressed
Glimepiride	Glimepiride	21	14
Finasteride	Finasteride	20	17
Atenolol	Atenolol	19	16
Ketoconazole	Ketoconazole	19	suppressed
Meloxicam	Meloxicam	18	14
Citalopram Hbr	Citalopram Hydrobromide	17	14
Entresto	Sacubitril/Valsartan	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Lactulose	Lactulose	15	12
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	14
Baclofen	Baclofen	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Mupirocin	Mupirocin	14	13
Oxybutynin Chloride Er	Oxybutynin Chloride	14	11
Xarelto	Rivaroxaban	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cefdinir	Cefdinir	13	13
Cyproheptadine Hcl	Cyproheptadine Hcl	13	12
Memantine Hcl	Memantine Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Allopurinol	Allopurinol	12	12
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	11
Lidocaine	Lidocaine	12	11
Novolog	Insulin Aspart	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error